Cargando…
Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR‐Driven Lung Cancer
Lung cancer is the leading cause of cancer death worldwide. Vaccination against EGFR can be one of the venues to prevent lung cancer. Blocking glutamine metabolism has been shown to improve anticancer immunity. Here, the authors report that JHU083, an orally active glutamine antagonist prodrug desig...
Autores principales: | Huang, Mofei, Xiong, Donghai, Pan, Jing, Zhang, Qi, Sei, Shizuko, Shoemaker, Robert H., Lubet, Ronald A., Montuenga, Luis M., Wang, Yian, Slusher, Barbara S., You, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475521/ https://www.ncbi.nlm.nih.gov/pubmed/35861366 http://dx.doi.org/10.1002/advs.202105885 |
Ejemplares similares
-
Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine
por: Pan, Jing, et al.
Publicado: (2017) -
Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention
por: Lee, Sang Beom, et al.
Publicado: (2023) -
Precision immunointerception of EGFR-driven tumorigenesis for lung cancer prevention
por: Pan, Jing, et al.
Publicado: (2023) -
Vaccines for immunoprevention of DNA mismatch repair deficient cancers
por: Hernandez-Sanchez, Alejandro, et al.
Publicado: (2022) -
Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator
por: Pan, Jing, et al.
Publicado: (2019)